Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MDByPrerna Mewawalla, MD,Maggie L. ShawAugust 13th 2026
Closing the Gap Between Myeloma Science and Access: Doris Hansen, MDByMaggie L. Shaw,Doris Hansen, MDAugust 5th 2026
Expanding Community Access to CAR T, Bispecific Therapies in Multiple Myeloma: Peter Forsberg, MDBySabrina McCrear,Peter Forsberg, MDAugust 4th 2026
Expanding Access to CAR T, Bispecific Therapies Requires System Changes: Peter Forsberg, MDBySabrina McCrear,Peter Forsberg, MDAugust 3rd 2026